**Core tip:** Utilizing the opened round ligament as venous grafts during liver transplantation is useful but controversial, and there are no pathological analyses of this procedure. Herein, we describe the first reported case of pathological analysis of an opened round ligament used as a venous patch graft in living donor liver transplantation. The hepatic venous (HV) anastomotic site had no stenosis or thrombus on autopsy. On pathology, there was adequate patency and continuity between the recipient's HV and the donor's opened round ligament. In addition, the stains for CD31 and CD34 on the inner membrane of the opened round ligament were positive.

INTRODUCTION
============

The use of the opened round ligament as a venous patch graft has become accepted in hepatopancreatobiliary surgery because of its easy availability\[[@B1]-[@B3]\]. Recent studies have demonstrated the use of the opened round ligament as a venous patch graft in hepatic venous reconstruction during living donor liver transplantation (LDLT)\[[@B4]-[@B7]\]. However, there is no consensus regarding the efficacy of using the opened round ligament as a venous patch graft. Although there are reports on the radiological patency of the opened round ligament after LDLT and reports on the pathological assessment of its epithelium at the time of transplant\[[@B8],[@B9]\], pathological analyses of long-term patency and continuity after LDLT have not been reported.

Herein, we describe the first reported case of a pathological analysis on an autopsy specimen of an opened round ligament used as a venous patch graft in hepatic venous reconstruction during LDLT. Approval to conduct this study was obtained from the Ethics Committees of Jichi Medical University.

CASE REPORT
===========

A 13-year-old female patient with biliary atresia was considered for LDLT because of decompensated liver cirrhosis with jaundice. Her body height and weight were 159.4 cm and 54.0 kg, respectively, and her standard liver volume was 1095 mL. The blood test results were as follows: white blood cells 9600/μL; hemoglobin 8.7 g/dL; hematocrit 26.0%; platelets 149000 /μL; albumin 2.9 g/dL; creatinine 0.35 mg/dL; total bilirubin 31.6 mg/dL; aspartate aminotransferase 93 mU/mL; alanine aminotransferase 50 mU/mL; prothrombin time-international normalized ratio 1.40; and activated partial thromboplastin 58.3 s. The model for end-stage liver disease score was 23.

The patient underwent an ABO-compatible LDLT using her mother's posterior segment graft (390 g; graft volume to standard liver volume ratio: 35.6%). The graft had two hepatic veins (HVs), including the right hepatic vein (RHV; 15 mm) and the inferior RHV (IRHV; 20 mm) (Figure [1A](#F1){ref-type="fig"}). The graft RHV and IRHV were formed into a single orifice using the donor's opened round ligament (60 mm × 20 mm) as a venous patch graft during bench surgery (Figure [1B](#F1){ref-type="fig"}); it was then anastomosed end-to-side with the recipient inferior vena cava (Figure [1C](#F1){ref-type="fig"} and D). Portal vein reconstruction using an interposition vein graft from the right saphenous vein of the donor was performed between the recipient portal vein and the graft posterior portal vein. Hepatic artery reconstruction using microsurgical technique was performed between the recipient right hepatic artery and the graft posterior hepatic artery. For biliary reconstruction, a Roux-en-Y hepaticojejunostomy was performed. Intraoperative color Doppler ultrasonography was performed to assess the blood flow velocity and pattern after vascular reconstruction, and the flow velocity and pattern were satisfactory. The length of the operation was 21 h and 8 min, and the bleeding volume was 7438 mL. Tacrolimus and methylprednisolone were used for standard post-operative immunosuppressive therapy.

![The graft had two hepatic veins. Including the right hepatic vein (RHV; 15 mm) and the inferior RHV (IRHV; 20 mm) (A). The graft RHV and IRHV were formed into a single orifice using the donor's opened round ligament (60 mm × 20 mm) as a venous patch graft during bench surgery (B). It was then anastomosed end-to-side with the recipient inferior vena cava (C and D).](WJG-22-7851-g001){#F1}

On post-operative day (POD) 8, portal vein thrombosis was detected by color Doppler ultrasonography, and the patient was given intravenous urokinase. On POD 26, acute cellular rejection was diagnosed by a graft liver biopsy, and she was treated with pulse steroids. On POD 40, cytomegalovirus viremia was detected by the C7-HRP test, and she underwent preemptive anti-cytomegalovirus therapy. On POD 48, portal vein balloon dilatation was performed by interventional radiology after the progressive narrowing of the portal vein anastomotic stricture to less than 2 mm was detected by color Doppler ultrasonography. During percutaneous transhepatic portography of the intrahepatic portal vein, bilhemia was detected, and thereafter, she suffered from persistent jaundice (total bilirubin 6.4 mg/dL). On POD 86, she developed a fever with liver dysfunction, and antibiotic treatment for acute cholangitis was administered. However, she died of septic shock with persistent cholangitis and bacteremia (with *Serratia marcescens*) on POD 88.

There were no post-transplant complications involving the HVs, and the radiological patency between the opened round ligament and the HV was confirmed on POD 82 (Figure [2](#F2){ref-type="fig"}). The HV anastomotic site had no stenosis or thrombus on an autopsy (Figure [3A](#F3){ref-type="fig"} and B). The patency and continuity between the donor's opened round ligament and the HV were adequate on pathological examination. In addition, the stains for CD31 and CD34 on the inner membrane of the opened round ligament were positive, a finding also observed in the graft HV (Figure [3C](#F3){ref-type="fig"} and D).

![Abdominal enhanced computed tomography on post-operative day 82. The radiological patency of the donor's opened round ligament and the hepatic vein was confirmed (A, B, C, D). RHV: Right hepatic vein; IRHV: Inferior right hepatic vein.](WJG-22-7851-g002){#F2}

![Pathology of the hepatic venous anastomotic site on autopsy. No stenosis or thrombus was identified (A and B). On pathology, there was adequate patency and continuity between the recipient's hepatic vein and the donor's opened round ligament. In addition, the stains for CD31 and CD34 on the inner membrane of the opened round ligament were positive, a finding also observed in the graft hepatic vein (C and D).](WJG-22-7851-g003){#F3}

DISCUSSION
==========

Outflow block in LDLT can potentially result in liver congestion, graft failure, and death\[[@B10]\]. When a right liver graft is used for LDLT and the graft HV is anastomosed end-to-end with the recipient HV or end-to-side with the recipient inferior vena cava, the liver graft expands in all directions in the limited right subphrenic space during liver graft regeneration. Consequently, the HV anastomosis can be compressed and twisted in some circumstances\[[@B11]\]. In addition, multiple HV reconstructions are sometimes required in a right liver graft LDLT. Therefore, reports have indicated that it is important to simplify HV reconstruction and enlarge the graft HV orifice by an all-in-one sleeve patch graft venoplasty, which has shown excellent outcomes\[[@B11]-[@B14]\].

The efficacy of various venous grafts used in HV reconstruction has been reported. These grafts include auto-venous grafts (from the inferior mesenteric vein, gonadal vein, external iliac vein, internal jugular vein, and saphenous vein)\[[@B13],[@B15],[@B16]\], venous grafts from a living donor, native portal veins\[[@B17]\], opened round ligaments\[[@B4]-[@B9],[@B12]\], cryopreserved homografts\[[@B18]-[@B22]\], and polytetrafluoroethylene grafts\[[@B23],[@B24]\]. However, the harvest of a venous graft from a living donor or the recipient himself is not easy. In addition, the availability of cryopreserved homografts is limited, and the adverse effects of polytetrafluoroethylene grafts are unclear. Alternatively, the opened round ligament is easier to use, and less invasive than other venous grafts, but it is controversial in regard to its long-term patency. Recently, use of the opened round ligament as a venous patch graft in hepatic venous reconstruction during LDLT has been reported\[[@B4]-[@B7]\]. Although there are reports on the radiological patency of the opened round ligament after LDLT and reports on the pathological assessment of its epithelium at the time of transplant\[[@B8],[@B9]\], there are no pathological analyses of patency and continuity. In this case, we conducted a pathological autopsy evaluation of a donor's opened round ligament used as a venous patch graft in LDLT. This is the first report that demonstrates the pathological efficacy of the opened round ligament after surgery. The HV anastomotic site had no stenosis or thrombus (Figure [3A](#F3){ref-type="fig"} and B). On pathology, there was adequate patency and continuity between the recipient HV and the donor's opened round ligament. In addition, the stains for CD31 and CD34 on the inner membrane of the opened round ligament were positive, a finding also observed in the graft HV (Figure [3C](#F3){ref-type="fig"} and D). Therefore, we believe that the pathological patency and the existence of venous endothelial cells support the efficacy of using the opened round ligament as a venous patch graft.

In conclusion, using the opened round ligament as a venous patch graft is easy, less invasive, and had been shown to be pathologically effective. The accumulation of further cases and the long-term observation of this case are needed to confirm our findings.
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COMMENTS
========

Case characteristic
-------------------

A 13-year-old female patient with biliary atresia underwent living donor liver transplantation using a posterior segment graft from her mother, and she died of septic shock with persistent cholangitis and jaundice 86 d after living donor liver transplantation.

Clinical diagnosis
------------------

The patient was diagnosed septic shock with persistent cholangitis and jaundice 86 d after living donor liver transplantation.

Differential diagnosis
----------------------

No-obstructive afferent loop syndrome.

Laboratory diagnosis
--------------------

Biliary stasis.

Imaging diagnosis
-----------------

The radiological patency between the opened round ligament and the hepatic vein was confirmed on POD 82.

Pathological diagnosis
----------------------

On pathology, there was adequate patency and continuity between the recipient's hepatic vein and the donor's opened round ligament. In addition, the stains for CD31 and CD34 on the inner membrane of the opened round ligament were positive, a finding also observed in the graft hepatic vein.

Treatment
---------

The antibiotic treatment for acute cholangitis was administered.

Related reports
---------------

The efficacy of various venous grafts used in hepatic vein reconstruction has been reported. These grafts include auto-venous grafts (from the inferior mesenteric vein, gonadal vein, external iliac vein, internal jugular vein, and saphenous vein), venous grafts from a living donor, native portal veins, opened round ligaments, cryopreserved homografts, and polytetrafluoroethylene grafts.

Term explanation
----------------

Opened round ligament and all-in-one venoplasty.

Experiences and lessons
-----------------------

Hepatic venous reconstruction using the opened round ligament as a venous patch graft is effective in living donor liver transplantation, as observed on pathology.

Peer-review
-----------

The manuscript provides anecdotal support for the use of opened round ligament in hepatic vein reconstruction.
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